Fully human intranasal foralumab shows promise in treating Secondary Progressive Multiple Sclerosis, Alzheimer's, and ALS.

For the study, researchers compared blood samples from 139 patients with ALS against 70 from patients with other similar ...

Tell your healthcare provider right away or go to the nearest emergency room if you have any of the following symptoms: hives ...

Asceneuron is the latest biotech to face setbacks in developing tau-targeting therapies for Alzheimer’s. After Eli Lilly and ...

Motor neuron diseases are a group of fatal progressive disorders that rob the body and brain of the ability to function.

Positron emission tomography (PET) is a nuclear imaging technique used to diagnose conditions such as cancer. An innovative ...

“This is a wonderful piece of work,” said Henrik Zetterberg at the University of Gothenburg, Sweden. He was not involved in the research. “It now seems possible to use [plasma p-Tau217] to track the ...

Multiple system atrophy (MSA) is not exactly a household word – a situation that Alterity Therapeutics is seeking to change.

A new map has begun to build a picture of motor neuron disease (MND) in NSW, with the team at Australia's first MND ...

Amylyx began the Phase 1 LUMINA clinical trial of AMX0114, an investigational antisense oligonucleotide (ASO) targeting calpain-2, for people living with amyotrophic lateral sclerosis (ALS ... the FDA ...